SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041356
Filing Date
2023-08-10
Accepted
2023-08-10 16:18:32
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q drrx-20230630.htm   iXBRL 10-Q 2174940
2 EX-10.1 drrx-ex10_1.htm EX-10.1 51814
3 EX-31.1 drrx-ex31_1.htm EX-31.1 13945
4 EX-31.2 drrx-ex31_2.htm EX-31.2 13475
5 EX-32.1 drrx-ex32_1.htm EX-32.1 7006
6 EX-32.2 drrx-ex32_2.htm EX-32.2 7580
  Complete submission text file 0000950170-23-041356.txt   9232849

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drrx-20230630_lab.xml EX-101.LAB 383653
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT drrx-20230630_cal.xml EX-101.CAL 56290
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drrx-20230630.xsd EX-101.SCH 45724
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT drrx-20230630_def.xml EX-101.DEF 162850
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drrx-20230630_pre.xml EX-101.PRE 281612
55 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20230630_htm.xml XML 2173622
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31615 | Film No.: 231159769
SIC: 2834 Pharmaceutical Preparations